News

Man vs. Doctor

Our own Dr. Eli Pendleton suggests top keys to wellness for men.

Man vs. Doctor

by Melody Kitchen, ULP Marketing, posted in WELLNESS on June 13, 2014

“I know why men don’t like coming to see me,” explained Dr. Eli Pendleton, a family medicine doctor with UofL Physicians. “Men have a certain attitude, ‘Why should I go to the doctor?’ They associate the doctor with things they don’t want to do.”

The Centers for Disease Control and Prevention reports that women are twice as likely as men to visit the doctor for annual examinations and preventive services. According to Dr. Pendleton, what is unfortunate about that statistic is that many of the causes of death in men are preventable. In 2010, the CDC listed the top 10 causes of death for men as heart disease, cancer, unintentional injuries, chronic lower respiratory disease, stroke, diabetes, suicide, Alzheimer’s disease, kidney disease, flu and pneumonia.

“We live in coronary valley,” Dr. Pendleton said. “Look at how many of the top 10 causes of death revolve around heart disease. In many cases, men smoke, drink and eat more, and see the doctor less.”

But men need not fret according to Dr. Pendleton. He said men simply need to engage in preventative maintenance. “I encourage men to take care of themselves like they do the people and things that are important to them. A visit to my office doesn’t mean I’m going to poke and prod. We’re going to talk about your health and I’m going to put the responsibility back at my patient’s feet. We aren’t bulletproof. Our choices will catch-up with us.”

Dr. Pendleton suggests that the top keys to wellness are:

Pediatric Faculty Promoted

The following faculty members of the University of Louisville Department of Pediatrics have been promoted.

 

 

 

 


U of L GI well represented at AASLD

U of L GI well represented at AASLD

Craig J. McClain, M.D., discusses the similarities and key differences in alcoholic steatohepatitis (ASH) and non-alcoholic steatohepatitis (NASH) during a postgraduate course session at the AASLD Liver Meeting.

Postgraduate course examines inflammation and steatohepatitis

Members of the University of Louisville Division of Gastroenterology, Hepatology & Nutrition and their collaborators presented the following abstracts at the 2014 American Association for the Study of Liver Disease (AASLD) Liver Meeting held November 7-11, 2014 in Boston:

  • Transient Receptor Potential Vanilloid 1 Gene Deficiency Ameliorates Hepatic Injury in a Mouse Model of Chronic-Binge-Induced Alcoholic Liver Disease - Irina Kirpich, Huilin Liu, K. Cameron Falkner, Juliane I. Beier, Gavin E. Arteel, Christopher Ramsden, Ariel E. Feldstein, Craig McClain
  • Post-Transplant Hepatitis C Reinfection Following Prolonged Pre-transplant Viral Suppression with Sofosbuvir Plus Ribavirin in a Hepatocellular Carcinoma Patient Wait-Listed For Orthotopic Liver Transplantation - Eric Davis, Neil Crittenden, Barbra Goshko, Matt Cave
  • Single Center Experience with Simeprevir/Sofosbuvir Combination Therapy for Recurrent Hepatitis C Virus Infection in Liver Transplant Recipients - Neil Crittenden, Eric Davis, Luis Marsano, Craig McClain, Ashutosh Barve, Barbra Goshko, Rob Tatum, Mike Hughes, Chris Jones, Michael R Marvin, Matt Cave
  • The protective role of CAR and PXR in Aroclor 1260-induced Steatohepatitis - B. Wahlang,  K.C. Falkner, M. Song, H. Clair, R. Prough, and M. Cave
  • Suspected Toxicant Associated Steatohepatitis (TASH) in Residents Living Near an Abandoned Chemical Manufacturing Complex - I.Kirpich, M.Mohammad, K.C.Falkner, H.B. Clair, G.E. Arteel, R.A. Prough, M.Cave
  • Phosphodiesterase 4 (PDE4) plays a significant role in alcohol induced dysregulation of lipid metabolism and development of hepatic steatosis - D. V. Avila, J. Zhang, C. J. McClain, S. Barve, and L.Gobejishvili
  • Lipid-derived aldehyde, acrolein, is a critical mediator of alcohol-induced gut-liver injury in alcoholic liver disease - Wei-Yang Chen, Jingwen Zhang, Shirish Barve, Craig McClain, and Swati Joshi-BarveExposure to Vinyl Chloride Metabolites Exacerbates Liver Injury Caused by High Fat Diet in Mice - Lisanne C Anders, Amanda N Douglas, Adrienne M Bushau, Keith C Falkner, Gavin E Arteel, Matt Cave, Craig J McClain and Juliane I Beier
  • 9(S)-hydroxy-octadecadienoic acid (HODE) enhances interleukin-1β production of PBMCs from alcoholic liver cirrhosis patients by activation of TRPV1 - Qifa Xie, Mohammad Mohammad, Matthew Cave, Shirish Barve, Irina Kirpich, Craig McClain
  • Oral Administration of Tributyrin Attenuates Chronic Ethanol-Induced Hepatic Steatosis, Inflammation and Injury - H. Donde, J. Zhang, S. Ghare, L. Gobejishvili, S. Joshi-Barve, V. Vatsalya, C.J. McClain and S. Barve
  • Interactions between the gut permeability, blood endotoxemia and liver injury in alcoholic patients during detoxification - Irina A.Kirpich, John Umhau, Vatsalya Vatsalya, Melanie Schwandt, Monte Phillips, Timothy Lionetti,  K.Cameron Falkner, Lucy Zhang, Catey Harwell, David T.George, Markus A. Heilig, Craig J. McClain
  • Fibroblast Growth Factor 21 Deficiency Exacerbates Chronic Alcohol-Induced Hepatic Steatosis and Injury in Mice - Cuiqing Zhao, Liming Liu, Fengyuan Li, Craig McClain, Wenke Feng
  • Serum fibroblast growth factor 19 levels are increased in subjects with alcoholic cirrhosis and positively associated with serum total bile acid levels - Cuiqing Zhao, Mohammad Mohammad, Liming Liu, Keith C. Falkner, Zhanxiang Zhou, Craig J. McClain, Wenke Feng, Matthew C. Cave
  • Zinc Sulfate for Alcoholic Cirrhosis (ZAC) Clinical Trial-Interim Analysis of Clinical Parameters, Intestinal Permeability and Liver Fibrosis Biomarkers - Ming Song, Mohammad K. Mohammad, Cam Falkner, Craig J. McClain, Matthew C. Cave
  • Zinc Sulfate for Alcoholic Cirrhosis (ZAC) Clinical Trial-Interim Analysis of Liver Injury/Inflammation Biomarkers - Mohammad K. Mohammad, Ming Song, Falkner K.C., Craig J. McClain, Matthew C. Cave
  • Elevated biomarker-indicated liver disease and pro-inflammatory cytokines are associated with environmental PCB exposure in Anniston, Alabama - H.B. Clair, K.C. Falkner, B. Wahlang, R.A. Prough, and M. Cave
  • Proteomics analysis of liver from mice with high fat diet-induced fatty liver disease identifies inhibition of HNF4a as a mechanism by which arsenic promotes progression to steatohepatitis - Walter H. Watson, Tom J. Burke, Veronica L. Massey, Gavin E. Arteel, Michael L. Merchant
  • Quetiapine Fumarate XR showed better clinical management in elevated liver injury during titration phase in very heavy drinkers - H. Donde, V. Vatsalya, C. J. McClain, S. S. Barve
  • Lack of antiviral therapy response is associated with elevated circulating levels of cytokeratin-18 and inflammatory cytokine IL-8 in patients with chronic hepatitis C - Bryan Lamoreau, Smita Ghare, Shirish Barve, Craig McClain, and Swati Joshi-Barve

    Rodriguez named Leukemia and Lymphoma Society Man of the Year

    Personal care and dedication to his patients leads to recognition.
    Rodriguez named Leukemia and Lymphoma Society Man of the Year

    Cesar Rodriguez, M.D.


    There are compelling reasons why Cesar Rodriguez, M.D., has been named Leukemia and Lymphoma Society’s Man of the Year.

    For one, the oncologist and hematologist who serves as an assistant professor of medicine in the University of Louisville Division of Blood and Bone Marrow Transplantation raised more money for the society than any other person raised within the 10-week period that ended May 30, according to the society’s executive director, Shane Stuber.

    "Dr. Rodriguez raised over $32,000," Stuber said. "He did that by hosting a couple of events, using social media, running an email campaign, and getting sponsorships. KentuckyOne was one of the sponsors."

    For another, according to Stuber, Dr. Rodriguez is devoted to patients.

    "I have been at the James Graham Brown Cancer Center on Saturday afternoons, and I have seen Dr. Rodriguez making special rounds," Stuber said. "He puts his patients' needs above his own. There are great doctors, and there are special doctors. Dr. Rodriguez is both."

    The young physician focuses on bone marrow transplants and treating blood malignancies. The native of Mexico came to Louisville five years ago to complete a fellowship and a few years later he began to partner with the Leukemia and Lymphoma Society when he saw how much the society did.

    "All of my patients have benefited from the society, whether it be from help with co-pays for medications, or help with gas money, or with education,” Rodriguez said. "I wanted to return something to the society for all they have done for cancer patients."

    Dr. Rodriguez' relatives are all back in Mexico. That makes his patients mean even more to him.

    "The nice thing about my specialty is that is gives me the opportunity to build a strong bond with my patients and their families," Rodriguez said. "There comes a time when they see me as if I'm part of their family instead of just being their doctor."

    And since they're like his family away from home, Dr. Rodriguez grieves over every untimely death, and rejoices with every remission.

    "The Leukemia and Lymphoma Society funds research to help find cures for blood cancers," Rodriguez said. "I am very involved with working on clinical research, and I use some investigational treatments on our patients. In several cases, these study drugs have saved their lives."

    Dr. Rodriguez has seen certain research medicines work so well that, "in some cases, there has been a dramatic turning point to their advantage. Maybe the drug cures them—or sometimes it allows them to live long enough to enjoy things they never would have imagined if not for these treatments. We’ve had patients get married. We’ve had patients watch their babies grow.

    "Obviously there are cases where we don’t see positive outcomes. But seeing these miracles keeps everybody going."

    About the Leukemia and Lymphoma Society of Kentucky

    The Leukemia and Lymphoma Society of Kentucky serves 4,000 adult and pediatric patients a year. Funds raised pay for financial assistance for patients and families, support groups for patients and family members, education and research. To donate to the society, contact Shane Stuber at shane.stuber@lls.org, or call 502-584-8490.

    Bookmark and Share

    DOM Lung Health Initiative group makes impact at 2014 ATS conference

    Louisville group makes its mark at international meeting in San Diego.
    DOM Lung Health Initiative group makes impact at 2014 ATS conference

    Pulmonologists from across the globe, including a contingent from the U of L Department of Medicine's Lung Health Initiative, converged in May in San Diego for thd 2014 American Thoracic Society International Conference.


    Several members of the University of Louisville Division of Pulmonary, Critical Care & Sleep Disorders Medicine and the U of L Department of Medicine Lung Health Initiative (LHI) participated in the recent 2014 American Thoracic Society International Conference, an annual meeting of the largest respiratory society in the world.

    Among the highlights for the U of L contingent include:

    • Members of the LHI participated in activities related to the Health Equality Initiative of the ATS, an initiative that has become a center piece of the society’s strategy towards reducing health disparities. The May issue of the Annals of the ATS focused on this area.
    • Department of Medicine Chairman Dr. Jesse Roman ended his term as Chair of the ATS Respiratory Cell & Molecular Biology (RCMB) Assembly and accepted the position of Chair of the Medical Advisory Board of the Pulmonary Fibrosis Foundation.  He also served on the new RCMB Working Group on the Future of Idiopathic Pulmonary Fibrosis Research, participated in a panel discussion about Careers for Junior Investigators, facilitated poster discussion sessions on interstitial lung disease, and delivered a lecture in the session Breakthroughs of the Year: Aging and Senescence.
    • Researchers from the LHI Lung Cancer Team presented novel observations about the mechanisms by which nicotine promotes lung cancer (Edilson Torres-Gonzalez and John Greenwell).
    • The LHI Lung Interstitial Lung Disease Team presented on the role of aging in lung tissue remodeling and fibrosis and how tobacco influences these processes (Glenn Vicary and Jeffrey Ritzenthaler).  They also presented information about sarcoidosis (Karim El-Kersh, Tanya Wiese, Rafael Perez).
    • The LHI Critical Care Medicine Team discussed the role of lactate levels in critically ill patients (Rodrigo Cavallazzi).
    • The LHI Pulmonary Hypertension Team presented cases requiring innovative approaches to the management of pulmonary hypertension and pulmonary embolism (Patton Thompson, J. Shaun Smith). They also presented information on histone deacetylase inhibitors using animal models of pulmonary vascular disease (Igor Zelko and Rodney Folz).
    • Members of the LHI COPD Team presented new methods for stimulation of abdominal muscles to improve breathing and related areas (Rodney Folz).
    • The LHI Lung Transplantation Team presented on allograft rejection (David Nunley, Victor Van Berkel, Allan Ramirez).

    In addition, Pulmonary/CCM Fellows in from the pulmonary division participated in the Fellows Track Symposia  and presented the following posters:


    Bookmark and Share

    DOM Lung Health Initiative group makes impact at 2014 ATS conference

    Louisville group makes its mark at international meeting in San Diego.
    DOM Lung Health Initiative group makes impact at 2014 ATS conference

    Pulmonologists from across the globe, including a contingent from the U of L Department of Medicine's Lung Health Initiative, converged in May in San Diego for thd 2014 American Thoracic Society International Conference.


    Several members of the University of Louisville Division of Pulmonary, Critical Care & Sleep Disorders Medicine and the U of L Department of Medicine Lung Health Initiative (LHI) participated in the recent 2014 American Thoracic Society International Conference, and annual meeting of the largest respiratory society in the world.

    Among the highlights for the U of L contingent include:

    • Members of the LHI participated in activities related to the Health Equality Initiative of the ATS, an initiative that has become a center piece of the society’s strategy towards reducing health disparities. The May issue of the Annals of the ATS focused on this area.
    • Department of Medicine Chairman Dr. Jesse Roman ended his term as Chair of the ATS Respiratory Cell & Molecular Biology (RCMB) Assembly and accepted the position of Chair of the Medical Advisory Board of the Pulmonary Fibrosis Foundation.  He also served on the new RCMB Working Group on the Future of Idiopathic Pulmonary Fibrosis Research, participated in a panel discussion about Careers for Junior Investigators, facilitated poster discussion sessions on interstitial lung disease, and delivered a lecture in the session Breakthroughs of the Year: Aging and Senescence.
    • Researchers from the LHI Lung Cancer Team presented novel observations about the mechanisms by which nicotine promotes lung cancer (Edilson Torres-Gonzalez and John Greenwell).
    • The LHI Lung Interstitial Lung Disease Team presented on the role of aging in lung tissue remodeling and fibrosis and how tobacco influences these processes (Glenn Vicary and Jeffrey Ritzenthaler).  They also presented information about sarcoidosis (Karim El-Kersh, Tanya Wiese, Rafael Perez).
    • The LHI Critical Care Medicine Team discussed the role of lactate levels in critically ill patients (Rodrigo Cavallazzi).
    • The LHI Pulmonary Hypertension Team presented cases requiring innovative approaches to the management of pulmonary hypertension and pulmonary embolism (Patton Thompson, J. Shaun Smith). They also presented information on histone deacetylase inhibitors using animal models of pulmonary vascular disease (Igor Zelko and Rodney Folz).
    • Members of the LHI COPD Team presented new methods for stimulation of abdominal muscles to improve breathing and related areas (Rodney Folz).
    • The LHI Lung Transplantation Team presented on allograft rejection (David Nunley, Victor Van Berkel, Allan Ramirez).

    In addition, Pulmonary/CCM Fellows in from the pulmonary division participated in the Fellows Track Symposia  and presented the following posters:

    U of L faculty show well at DDW 2014

    Several members of the University of Louisville Division of Gastroenterology, Hepatology & Nutrition were highlighted at the recent Digestive Disease Week 2014 conference held May 3-6, 2014 in Chicago.

    U of L faculty were well represented, including:

    • Motility: Dr. Thomas Abell’s motility program had over 10 presentations at DDW and accompanying satellite programs.

    • LiverDr. Craig McClain presented the state-of-the-art talk on “Nutrition, Gut Barrier Dysfunction and Fatty Liver Disease.”  Drs. Irina Kirpich, Swati Joshi-Barve and Juliane Beier all had oral presentations.

    • NutritionDr. Stephen McClave presented at a Meet-the-Professors luncheon and had several posters related to nutrition.

    • IBD/CancerDr. Gerald Dryden presented data on endoscopic injection of cytokine microbeads in a mouse model of colon cancer.

    Institute of Molecular Cardiology, Miller win MediStar Awards

    Accolades recognize innovation and leadership that lead to improvements in medical care.

    The Institute of Molecular Cardiology, under the leadership of Roberto Bolli, M.D., FAHA, received the Healthcare Innovation Award and Donald Miller, M.D., Ph.D., director of the James Graham Brown Cancer Center, was named the XLerateHealth Physician of the Year at the MediStar Awards presented May 13 at the Hyatt Regency Louisville.

    The Healthcare Innovation Award is presented to an organization that has developed a new procedure, device, service program or treatment that improves the delivery of medical care.

    Under the leadership of Bolli, Chief of the U of L Division of Cardiovascular Medicine and the Jewish Hospital Heart & Lung Institute Distinguished Chair in Cardiology, the Institute of Molecular Cardiology (IMC) has become recognized worldwide as a leading cardiovascular research program for its contributions in ischemic heart disease, heart failure, diabetes and obesity and adult stem cell therapy for cardiac repair and regeneration.

    Established in 2001, the IMC consistently brings more than $13 million annually in federal funding to the Louisville Metro region in developing novel treatments and future cures for the nation’s No. 1 killer, cardiovascular disease.

    The XLerateHealth Physician of the Year Award is conferred upon a physician who has shown outstanding leadership and vision and has contributed to his or her workplace, leaving a lasting legacy.

    Named director of the Brown Cancer Center in 1999, Miller also is the Chief of the Division of Medical Oncology & Hematology and the James Graham Brown Foundation Chair and Professor of Oncology and Associate Vice President for Health Affairs at U of L.

    Under his leadership, the JGBCC developed a nationally recognized leadership program in cancer drug development with more than two dozen novel treatments being studied and three entering early phase clinical trials. Miller’s own laboratory is currently studying short DNA sequences which are believed to cause cancer cell death; it is expected that treatments from his lab will enter clinical trials within the next two years.

    Since 2007 IGE Media, publisher of Medical News and Medical News For You, has recognized excellence at the annual MediStar Awards, honoring professionals, volunteers and programs for their impact on health care.

    Bookmark and Share

    Roman, U of L to host 'Fibrosis Across the Species' conference

    Researchers to discuss deadly lung disease affecting horses, dogs, cats, humans.
    Roman, U of L to host 'Fibrosis Across the Species' conference

    Hosted by the U of L Department of Medicine, researchers will meet in Louisville for the "Fibrosis Across the Species" conference to discuss and study pulmonary fibrosis and its effects on humans and animals


    Human lung disease researchers and veterinarians will meet April 27-29 at The Brown Hotel in Louisville for the "Fibrosis Across Species" workshop being convened by the Westie Foundation of America (WFA) and hosted by the University of Louisville's Medical Center and its Equine Center.

    Led by U of L Department of Medicine Chairman Dr. Jesse Roman, the unique conference takes place just days prior to the 140th running of the world famous Kentucky Derby.

    This unusual combination of human and veterinary scientists is tasked with creating a road map for comparative research in PF. Comparative research – or research that compares human disease to similar diseases in animals – has been used successfully in the treatment of cancer and, in fact, there is a comparative research division at the National Cancer Institute.

    "We are concerned about the growing incidence and prevalence of Pulmonary Fibrosis and realize that research done the customary way has limitations," Roman, a human PF researcher, said. "Studying animals, in particular horses and dogs, may allow us to better understand the underlying causes of this lung disease and how to best tackle finding life-saving treatments for all affected species."

    Pulmonary Fibrosis (PF) is a little known lung disease among most of the public, yet the disease claims as many human lives each year as breast cancer. In addition to horses, the disease is also known to affect cats, and dogs, especially terrier breeds of dog like the West Highland White Terrier (WHWT).

    There are no approved drugs for the disease in the United States, though a drug has been approved in Japan, the European Union and Canada.

    "We are pleased to convene this stellar team of scientists who will review and compare fibrotic disease in animals and humans and pave the way for major discovery," Bebe Pinter, CEO of the Westie Foundation of America said.

    The "Fibrosis Across Species" meeting will build on the success of a 2007 meeting, also convened by the WFA,that brought together human and veterinary scientists to discuss similarities between the WHWT and human forms of PF.

    The scientific paper from the 2007 meeting was published in the Annals of the American Thoracic Society. The paper identifies similarities across species and makes strong suggestions for a path forward. One of the experts’ recommendations is the convening of a meeting that fits the mold of the Fibrosis Across Species meeting.

    Many of the key researchers in that meeting will be leading the Louisville meeting along with key advocacy organizations, along with the WFA.

    ► For a full agenda for the meeting and to learn more, please visit www.westiefoundation.org.

    Bookmark and Share

    Roman, U of L to host 'Fibrosis Across the Species' conference

    Researchers to discuss deadly lung disease affecting horses, dogs, cats, humans.
    Roman, U of L to host 'Fibrosis Across the Species' conference

    Hosted by the U of L Department of Medicine, researchers will meet in Louisville for the "Fibrosis Across the Species" conference to discuss and study pulmonary fibrosis and its effects on humans and animals


    Human lung disease researchers and veterinarians will meet April 27-29 at The Brown Hotel in Louisville for the "Fibrosis Across Species" workshop being convened by the Westie Foundation of America (WFA) and hosted by the University of Louisville's Medical Center and its Equine Center.

    Led by U of L Department of Medicine Chairman Dr. Jesse Roman, the unique conference takes place just days prior to the 140th running of the world famous Kentucky Derby.

    This unusual combination of human and veterinary scientists is tasked with creating a road map for comparative research in PF. Comparative research – or research that compares human disease to similar diseases in animals – has been used successfully in the treatment of cancer and, in fact, there is a comparative research division at the National Cancer Institute.

    "We are concerned about the growing incidence and prevalence of Pulmonary Fibrosis and realize that research done the customary way has limitations," Roman, a human PF researcher, said. "Studying animals, in particular horses and dogs, may allow us to better understand the underlying causes of this lung disease and how to best tackle finding life-saving treatments for all affected species."

    Pulmonary Fibrosis (PF) is a little known lung disease among most of the public, yet the disease claims as many human lives each year as breast cancer. In addition to horses, the disease is also known to affect cats, and dogs, especially terrier breeds of dog like the West Highland White Terrier (WHWT).

    There are no approved drugs for the disease in the United States, though a drug has been approved in Japan, the European Union and Canada.

    "We are pleased to convene this stellar team of scientists who will review and compare fibrotic disease in animals and humans and pave the way for major discovery," Bebe Pinter, CEO of the Westie Foundation of America said.

    The "Fibrosis Across Species" meeting will build on the success of a 2007 meeting, also convened by the WFA,that brought together human and veterinary scientists to discuss similarities between the WHWT and human forms of PF.

    The scientific paper from the 2007 meeting was published in the Annals of the American Thoracic Society. The paper identifies similarities across species and makes strong suggestions for a path forward. One of the experts’ recommendations is the convening of a meeting that fits the mold of the Fibrosis Across Species meeting.

    Many of the key researchers in that meeting will be leading the Louisville meeting along with key advocacy organizations, along with the WFA.

    ► For a full agenda for the meeting and to learn more, please visit www.westiefoundation.org.

    Bookmark and Share

    Student Marathon Runners Award Medals to Pediatric Patients

    Student Marathon Runners Award Medals to Pediatric Patients

    This is the UofL School of Medicine's sixth year to participate in Medals4Mettle.

    University of Louisville medical student runners marked the end of the Kentucky Derby Festival Marathon and the university’s sixth Medals4Mettle season by presenting their hard-earned medals to pediatric patient “running buddies.”

    This year, 75 med students were paired with children being treated by UofL pediatric specialists. The patients range in age from 18 months to young adultand have been diagnosed with conditions such as brain cancer, bone cancer, hemophilia, leukemia and sickle cell disease. (read more)

    Click here for more photos from the event.

    U of L cardiologists to take part in women's heart disease symposium

    One-day conference to address current guidelines and trends in the field of cardiovascular medicine.
    U of L cardiologists to take part in women's heart disease symposium

    Several U of L cardiologists will take part in 2014 Louisville Symposium on Heart Disease in Women at Jewish Hospital's Rudd Heart & Lung Center.


    Several doctors with the University of Louisville Division of Cardiovascular Medicine are set to speak at the 2014 Louisville Symposium on Heart Disease in Women.

    The conference will be held Saturday, June 28, at the Rudd Heart & Lung Center, 16th Floor Conference Center, 201 Abraham Flexner Way, in Louisville. The conference will begin at 7 a.m. with registration and a continental breakfast, with the program starting at 8 a.m. The event will end at 5 p.m.

    Cardiovascular disease, including heart disease, hypertension and stroke, is the No. 1 killer of women in the United States. Long thought to be a disease primarily affecting men, cardiovascular disease actually kills more women than men on an annual basis.

    Although heart disease is a multi-factored, complex disorder, it is preventable, but education for both patients and health care professionals about the prevention, recognition and treatment of heart disease in women is essential.

    READ THE FULL ARTICLE

    Louisville Symposium on Heart Disease in Women web site

    Bookmark and Share

    Gregory Barnes named director of UofL Autism Center

    Gregory Barnes, M.D., Ph.D., is the inaugural permanent director of the University of Louisville Autism Center. Barnes comes to UofL from Vanderbilt University. Barnes also will hold the Spafford Ackerly Chair for Child and Adolescent Psychiatry and faculty positions in the departments of Neurology and Pediatrics.(more)

     

    UofL Pediatrician Elected to Medical Honor Society

    University of Louisville pediatrician V. Faye Jones, M.D., Ph.D, MSPH, has been elected to Alpha Omega Alpha Honor Medical Society. Practicing physicians are elected to the society in recognition of their scholarly achievements and professional contributions. Nearly 75 percent of U.S. medical school deans are members of AΩA. The honor society also includes more than 50 Nobel Prize winners.

    A professor of pediatrics, Dr. Jones is the medical director of UofL Physicians Pediatrics-Broadway, a primary care teaching practice of the UofL Department of Pediatrics.

    She also serves as the university’s Assistant Vice President for Health Affairs/Diversity Initiatives. In this position, Dr. Jones oversees the Office of Diversity and Inclusion, which works to promote an environment of inclusiveness throughout all of the UofL Health Sciences Center schools. Previously, she was the Associate Dean for Academic Affairs and was responsible for the UofL School of Medicine Office of Minority and Rural Affairs.

    Dr. Jones completed medical school and her pediatric residency at the University of Louisville and began practicing pediatrics in 1988 at an inner city clinic in Milwaukee. She returned to Louisville in 1990. She earned a master’s degree from U of L’s School of Public Health in 2001 and a doctorate in 2006.

    Match Day a perfect success

    U of L Internal Medicine Residency Program again fills all of its available openings.
    Match Day a perfect success

    A student holds up his letter from the NRMP as University of Louisville medicial school graduates celebrated Match Day 2014 at the Old Medical School.


    U of L MATCH DAY PHOTO GALLERY

    It's "Match Madness" all over again.

    Match Day for University of Louisville medical students, and others nationwide, was March 21 as they opened their envelopes from the National Residency Match Program to find where they had been matched for residency training.

    The U of L Internal Medicine Residency Program completed a perfect match yet again, filling all 24 categorical and 15 preliminary positions.

    "The Internal Medicine Residency Training Program at U of L is delighted to welcome our new class of interns who will begin their training on July 1," Dr. Barbara Casper, director of the U of L Internal Medicine Residency Program said. "They are an extremely bright group of folks who are also a lot of fun and I know we will enjoy having the opportunity of watching them grow as physicians in the upcoming years. We are very excited that we had such a successful match again this year and are also very pleased that our medical students were so successful in matching with their residency of choice! It was a great match for the entire institution and reflects the caliber of students that we train and recruit!"

    Conducted annually by the NRMP, The Match uses a computerized algorithm designed to the best results by aligning the preferences of applicants with the preferences of residency programs.

    The results are used to fill thousands of training positions available in the United States.

    Our incoming Class of 2017 includes:

    Categorical Residents

    • Shifat Ahmed - University of Arizona College of Medicine
    • Lisanne Anders - Medizinische Fakultät Mannheim, Ruprecht-Karls-Universität Heidelberg
    • Christopher Angus - Georgetown University School of Medicine
    • Hilda Azabache Orrillo - University of Tennessee Health Science Center College of Medicine
    • Corey Cavanaugh - Ohio University Heritage College of Osteopathic Medicine
    • Christopher Clarke - University of Louisville School of Medicine
    • Imad Jaafar - University of Louisville School of Medicine
    • Nikhil Kadle - Medical College of Georgia at Georgia Regents University
    • Fahad Khan - Medical College of Georgia at Georgia Regents University
    • Richard Yoon Ho Kim - St. George's University School of Medicine
    • Andrew Kiser - Medical University of South Carolina College of Medicine
    • Yash Kothari - St. George's University School of Medicine

     

    • Nanlong Liu - Medical College of Georgia at Georgia Regents University
    • Suzanne McGee - University of Louisville School of Medicine
    • Christopher Migliore - Rush Medical College of Rush University Medical Center
    • Takudzwa Mkorombindo - University of Louisville School of Medicine
    • Aniruddh Patel - Medical University of South Carolina College of Medicine
    • Robert Pearce - University College Dublin School of Medicine and Medical Science
    • Brittany Peterson - Ohio University Heritage College of Osteopathic Medicine
    • John Price - West Virginia School of Osteopathic Medicine
    • Taj Rahman - St. George's University School of Medicine
    • Jeffrey Rogers - University of Kentucky College of Medicine
    • Bilal Salame - St. George's University School of Medicine
    • Nelson Seabrook - Medical University of South Carolina College of Medicine

     

    Preliminary Residents

    • Shakeeb Ahmad - University of Louisville School of Medicine
    • Brenton Bohlig - St. George's University School of Medicine
    • Ashley Dickinson - University of Louisville School of Medicine
    • Josh Gross - University of Louisville School of Medicine
    • Jeremy Haysley - University of Louisville School of Medicine
    • Seth Haywood - University of Louisville School of Medicine
    • Adrianna Henson - University of Louisville School of Medicine
    • Audra Isaac - University of Louisville School of Medicine

     

    • Tala Kassm - A.T. Still University School of Osteopathic Medicine
    • Jeffrey Kinner - University of Louisville School of Medicine
    • Jennifer Moody - University of Louisville School of Medicine
    • Brett Mueller II - University of North Texas Health Science Center - Texas College of Osteopathic Medicine
    • Mark Mugavin - University of Louisville School of Medicine
    • William Wilson IV - University of Louisville School of Medicine
    • Chandresh Shah - University of Louisville School of Medicine

     


    Bookmark and Share

    Happy St. Patrick’s Day! Green Beer!

    It's St. Patrick’s Day and many pubs and restaurants are serving green beer to mark the occasion. While many people down the green beer without a second thought, some might be wondering, what’s in it, and is it bad for you?

    St. Patrick's Day: Is green beer bad for your health?

    See what Dr. Eli Pendleton recommends...

    Jorizzo delivers inaugural Callen Lecture

    Founder of Wake Forest dermatology department delivers first-ever presentation of newly endowed lecture series.
    Jorizzo delivers inaugural Callen Lecture

    U of L Chief of Dermatology Dr. Jeffrey Callen (left) with Dr. Joe Jorizzo (right), the first-ever speaker for the newly endowed Jeffrey P. Callen Dermatology Lecture.


    The first endowed Jeffrey P. Callen Dermatology Lecture was given to the faculty and residents at the University of Louisville Dermatology program by Joe Jorizzo M.D., on March 4, 2014.

    Jorizzo is Professor, and former and founding Chair of the Department of Dermatology at Wake Forest University and Adjunct Professor of Dermatology at the Weill Cornell School of Medicine.

    Named for Jeffrey P. Callen, M.D., FACP, FAAD, the lectureship was begun by his wife Susan and a committee of alumni to celebrate Dr. Callen's 25 years as Chief of the U of L Division of Dermatology.

    Callen began a lectureship series 37 years ago bringing in lecturers from all over the world to broaden the education of local doctors, and to put  U of L Dermatology on the map as one of the foremost clinical Dermatology programs in the country.

    The contributions will enable 5-6 lecturers per year in perpetuity. The goal of $250,000 has been funded 3/4 of the way, in one year.

    It wasn't he only honor for Callen as his faculty surprised him later by naming the library at their new location (3810 Springhurst Blvd.) in his honor.

    Those interested in further funding medical education can go to www.chartingourcourse.org and designate the Jeffrey P. Callen lectureship fund.

    Bookmark and Share

    CONGRATULATIONS, 2014-15 Chief Residents

    Congratulations to Jessica Schum, M.D. and Neil Patil, M.D. on being selected by their peers to serve as Chief Residents for 2014-2015 academic year.